Long-term management of plaque psoriasis with continuous efalizumab therapy

J Am Acad Dermatol. 2006 Apr;54(4 Suppl 1):S182-8. doi: 10.1016/j.jaad.2005.10.028.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Antibodies, Monoclonal / administration & dosage*
  • Antibodies, Monoclonal, Humanized
  • Clinical Trials as Topic
  • Humans
  • Immunologic Factors / administration & dosage*
  • Psoriasis / drug therapy*
  • Quality of Life
  • Treatment Outcome

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Immunologic Factors
  • efalizumab